Return to content in this issue

Successful Desensitization Protocol to Ivacaftor and a Compound of Elexacaftor/Tezacaftor/Ivacaftor in a Delayed Hypersensitivity Reaction Confirmed by Lymphocyte Transformation Test

Mir-Ihara P¹, De Las Vecillas L^1,2,3, Heredia R¹, Fiandor A^1,2,3, González-Muñoz M^2,4, Zamarrón E^2,5, Prados C^2,5, Cabañas R<sup>1,2,3,6

1</sup>Allergy Department. Hospital Universitario La Paz, Madrid, Spain
²Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
³PIELenRed Consortium
⁴Immunology Department. Hospital Universitario La Paz, Madrid, Spain
⁵Pulmonary Department. Hospital Universitario La Paz, Madrid, Spain
⁶Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain

J Investig Allergol Clin Immunol 2024; Vol. 34(3)
doi: 10.18176/jiaci.0961